Monetary Management Group’s Insmed INSM Stock Holding History

Monetary Management Group’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-500	Closed	-$87K	–	335
2025 Q4	$87K	Hold	500	–	–	0.02%	234
2025 Q3	$72K	Buy	+500	New	+$61.3K	0.02%	240

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Monetary Management Group's INSM Position: Q1 2026 in Review

Monetary Management Group sold out of Insmed (INSM) in Q1 2026, closing a stake of 500 shares — an estimated $87K sold.

Monetary Management Group first reported a position in INSM in Q3 2025 and held it in 2 quarters. The position peaked at $87K in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Monetary Management Group reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
Monetary Management Group sold 500 Insmed shares in Q1 2026, an estimated $87K.
Monetary Management Group first reported a position in Insmed in Q3 2025 and held it in 2 quarters.
Monetary Management Group's Insmed position peaked at $87K in Q4 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Monetary Management Group's 13F filing for Q1 2026, filed 13 May 2026.